These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 38021165)

  • 1. Overexpression of FNDC4 constrains ovarian cancer progression by promoting cell apoptosis and inhibiting cell growth.
    Li N; Li H; Zhou S; Zhang Q; Li G; Yi H; Liu Y; Ma Z
    J Cancer; 2023; 14(18):3416-3428. PubMed ID: 38021165
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Correlation of the prognostic value of FNDC4 in glioblastoma with macrophage polarization.
    Li H; Yan X; Ou S
    Cancer Cell Int; 2022 Sep; 22(1):273. PubMed ID: 36056336
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FNDC4 acts as an extracellular factor to promote the invasiveness of hepatocellular carcinoma partly via the PI3K/Akt signalling pathway.
    Wang B; Zheng B; Lu Y; Huang D; Liu J; Song J; Zheng S
    Cancer Med; 2021 Oct; 10(20):7242-7252. PubMed ID: 34418326
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prognostic value of transcriptional expression of fibronectin type III domain-containing 4 (FNDC4) in head and neck carcinoma patients treated with chemoradiotherapy.
    Camacho M; León X; Pujol A; Montezuma L; Quer M; García J
    Clin Transl Oncol; 2022 Nov; 24(11):2175-2180. PubMed ID: 35752749
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibronectin type III domain containing four promotes differentiation of C2C12 through the Wnt/β-catenin signaling pathway.
    Li J; Wang Y; Wang Y; Yan Y; Tong H; Li S
    FASEB J; 2020 Jun; 34(6):7759-7772. PubMed ID: 32298013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Shedding more light on the role of Midkine in hepatocellular carcinoma: New perspectives on diagnosis and therapy.
    Gowhari Shabgah A; Ezzatifar F; Aravindhan S; Olegovna Zekiy A; Ahmadi M; Gheibihayat SM; Gholizadeh Navashenaq J
    IUBMB Life; 2021 Apr; 73(4):659-669. PubMed ID: 33625758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. AHSA1 Regulates Hepatocellular Carcinoma Progression via the TGF-β/Akt-Cyclin D1/CDK6 Pathway.
    Gao Y; Li Y; Liu Z; Dong Y; Yang S; Wu B; Xiao M; Chen C; Wen Y; Chen L; Jiang H; Yao Y
    J Hepatocell Carcinoma; 2023; 10():2021-2036. PubMed ID: 38022728
    [TBL] [Abstract][Full Text] [Related]  

  • 8. HOXA-AS2 Promotes Proliferation and Induces Epithelial-Mesenchymal Transition via the miR-520c-3p/GPC3 Axis in Hepatocellular Carcinoma.
    Zhang Y; Xu J; Zhang S; An J; Zhang J; Huang J; Jin Y
    Cell Physiol Biochem; 2018; 50(6):2124-2138. PubMed ID: 30415263
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Prognostic and Immunotherapeutic Significance of AHSA1 in Pan-Cancer, and Its Relationship With the Proliferation and Metastasis of Hepatocellular Carcinoma.
    Li W; Liu J
    Front Immunol; 2022; 13():845585. PubMed ID: 35757728
    [TBL] [Abstract][Full Text] [Related]  

  • 10. FNDC4 Inhibits RANKL-Induced Osteoclast Formation by Suppressing NF-
    Lv ZT; Liang S; Chen K; Zhang JM; Cheng P; Guo JC; Yang Q; Zhou CH; Liao H; Chen AM
    Biomed Res Int; 2018; 2018():3936257. PubMed ID: 29977911
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overexpression of
    Yang P; Liu H; Li Y; Gao Q; Chen X; Chang J; Li Y; Chen S; Dong R; Wu H; Liu C; Liu G
    Front Genet; 2022; 13():959832. PubMed ID: 36299588
    [No Abstract]   [Full Text] [Related]  

  • 12. FNDC4 acts as an anti-inflammatory factor on macrophages and improves colitis in mice.
    Bosma M; Gerling M; Pasto J; Georgiadi A; Graham E; Shilkova O; Iwata Y; Almer S; Söderman J; Toftgård R; Wermeling F; Boström EA; Boström PA
    Nat Commun; 2016 Apr; 7():11314. PubMed ID: 27066907
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low expression of PIDD is associated with cell proliferation and apoptosis in hepatocellular carcinoma.
    Shi W; Huang W; Chen Y; Zhang S; Xu P; Gu X; Fan H; Xu J; Chen Y; Ni R; Lu C; Zhang X
    Tumour Biol; 2016 Aug; 37(8):10447-57. PubMed ID: 26846109
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression Analysis of Fibronectin Type III Domain-Containing (FNDC) Genes in Inflammatory Bowel Disease and Colorectal Cancer.
    Wuensch T; Wizenty J; Quint J; Spitz W; Bosma M; Becker O; Adler A; Veltzke-Schlieker W; Stockmann M; Weiss S; Biebl M; Pratschke J; Aigner F
    Gastroenterol Res Pract; 2019; 2019():3784172. PubMed ID: 31093274
    [TBL] [Abstract][Full Text] [Related]  

  • 15. LncRNA PCAT6 predicts poor prognosis in hepatocellular carcinoma and promotes proliferation through the regulation of cell cycle arrest and apoptosis.
    Luo Y; Lin J; Zhang Y; Dai G; Li A; Liu X
    Cell Biochem Funct; 2020 Oct; 38(7):895-904. PubMed ID: 32064636
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The significance of glypican-3 expression profiling in the tumor cellular origin theoretical system for hepatocellular carcinoma progression.
    Xue R; Feng J; Meng Q; Lv F; Zhu Y; Yu H; Zhang S; Song C; Sun L; Yue Z; Feng S; Che R; Xiang Q; Jing X
    J Gastroenterol Hepatol; 2017 Aug; 32(8):1503-1511. PubMed ID: 28087980
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Icaritin promotes apoptosis and inhibits proliferation by down-regulating AFP gene expression in hepatocellular carcinoma.
    Li H; Liu Y; Jiang W; Xue J; Cheng Y; Wang J; Yang R; Zhang X
    BMC Cancer; 2021 Mar; 21(1):318. PubMed ID: 33765973
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fibronectin Type III Domain Containing 4 attenuates hyperlipidemia-induced insulin resistance via suppression of inflammation and ER stress through HO-1 expression in adipocytes.
    Lee W; Yun S; Choi GH; Jung TW
    Biochem Biophys Res Commun; 2018 Jul; 502(1):129-136. PubMed ID: 29787756
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ADAM15 correlates with prognosis, immune infiltration and apoptosis in hepatocellular carcinoma.
    Xu JH; Guan YJ; Zhang YC; Qiu ZD; Zhou Y; Chen C; Yu J; Wang WX
    Aging (Albany NY); 2021 Aug; 13(16):20395-20417. PubMed ID: 34426560
    [TBL] [Abstract][Full Text] [Related]  

  • 20. EXOSC10 is a novel hepatocellular carcinoma prognostic biomarker: a comprehensive bioinformatics analysis and experiment verification.
    Meng ZY; Fan YC; Zhang CS; Zhang LL; Wu T; Nong MY; Wang T; Chen C; Jiang LH
    PeerJ; 2023; 11():e15860. PubMed ID: 37701829
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.